SCHEMBL9319407

SCHEMBL9319407

O=C(O)c1ccc(Cc2cc(Br)cc(Br)c2O)c(C(=O)O)c1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.50
AKR1C2 P52895 3/20 0.50
AKR1C1 Q04828 3/20 0.50
AKR1C4 P17516 2/20 0.50
TTR P02766 1/20 0.44
PTPN1 P18031 6/20 0.43
PTPN2 P17706 3/20 0.40
PTPN6 P29350 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 1/20 0.38
HMGB1 P09429 1/20 0.38
CXCL12 P48061 1/20 0.38
HSPD1 P10809 1/20 0.38
HSPE1 P61604 1/20 0.38
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11114049 0.82 AKR1C3 (0.56) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL19615026 0.79 AKR1C4 (0.50) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL9318199 0.76 AKR1C4 (0.47) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL67463 0.76 CYP3A4 (0.62) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL28729095 0.71 AKR1C3 (0.73) AKR1C3AKR1C2AKR1C1AKR1C4PTPN1
SCHEMBL9304917 0.69 AKR1C3 (0.44) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL29387062 0.69 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL330545 0.69 AKR1C3 (1.00) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL16050418 0.68 AKR1C4 (0.52) AKR1C3AKR1C2AKR1C1AKR1C4TTR
SCHEMBL825071 0.67 HSPA5 (0.57) TTRPTPN1ALDH1A1HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5290919-A Physiological oxygen carrier, artificial blood THE UNIVERSITY OF MARYLAND BALTIMORE (US) 1994-03-01 US disclosed